Daicel (JP:4202)
:4202
Want to see JP:4202 full AI Analyst Report?
4202 Stock Chart & Stats
¥1247.50
¥0.00(0.00%)
At close: 4:00 PM EST
¥1247.50
¥0.00(0.00%)
Day’s Range― - ―
52-Week Range¥1,112.50 - ¥1,658.00
Previous CloseN/A
Volume682.20K
Average Volume (3M)536.76K
Market Cap
¥304.37B
Enterprise Value¥539.87B
Total Cash (Recent Filing)¥75.85B
Total Debt (Recent Filing)¥317.90B
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Jul 30, 2026EPS Estimate
38.89Next Dividend Ex-DateN/A
Dividend Yield4.27%
Share Statistics
EPS (TTM)155.50
Shares Outstanding266,942,700
10 Day Avg. Volume480,400
30 Day Avg. Volume536,760
Financial Highlights & Ratios
PEG Ratio-0.40
Price to Book (P/B)0.91
Price to Sales (P/S)0.56
P/FCF Ratio128.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,440.00Price Target Upside15.43% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering2
EPS Forecast (FY)160.82
Revenue Forecast (FY)¥597.84B
Bulls Say, Bears Say
Bulls Say
Diversified B2B Product MixDaicel's portfolio spans safety-system components, engineering plastics and specialty chemicals sold into multiple industrial end markets. This diversification reduces single-market exposure, supports stable order flows from OEM/tier supply chains, and underpins durable demand across cycles.
Steady Multi-year Revenue GrowthConsistent top-line expansion over multiple years signals durable product-market fit and rising scale. Even with recent margin pressure, sustained revenue growth supports long-term capacity utilization benefits, pricing leverage in specialty product lines, and potential recovery in operating profit.
Improving Balance-sheet ResilienceA moderate leverage ratio and growing equity provide a stronger capital base to absorb shocks and fund capex. Improved balance-sheet metrics increase financial flexibility for strategic investments and reduce immediate refinancing strain compared with prior periods of higher leverage.
Bears Say
Profitability DeteriorationA marked decline in net income and operating margins erodes internal funding capacity and raises dependence on external financing. Sustained margin weakness reduces returns on invested capital, weakens cushioning against raw-material or energy cost spikes, and impairs long-term earnings visibility.
Volatile Free Cash FlowInconsistent free cash flow constrains reinvestment, dividends and debt repayment plans. Volatility implies working-capital swings or lumpy capex requirements, reducing the firm's ability to self-fund growth and making it more sensitive to cyclical downturns or funding cost increases.
Sizable Absolute Debt And Borrowing RelianceSignificant absolute debt increases interest expense risk and amplifies earnings volatility, particularly as profitability weakens. Reliance on borrowing limits strategic flexibility, raises refinancing risk in adverse markets, and could force prioritization between debt service and investment needs over the medium term.
Daicel News
4202 FAQ
What was Daicel’s price range in the past 12 months?
Daicel lowest stock price was ¥1112.50 and its highest was ¥1658.00 in the past 12 months.
What is Daicel’s market cap?
Daicel’s market cap is ¥304.37B.
When is Daicel’s upcoming earnings report date?
Daicel’s upcoming earnings report date is Jul 30, 2026 which is in 70 days.
How were Daicel’s earnings last quarter?
Daicel released its earnings results on May 12, 2026. The company reported -¥96.24 earnings per share for the quarter, missing the consensus estimate of ¥51.879 by -¥148.119.
Is Daicel overvalued?
According to Wall Street analysts Daicel’s price is currently Undervalued.
Does Daicel pay dividends?
Daicel pays a Semiannually dividend of ¥30 which represents an annual dividend yield of 4.27%. See more information on Daicel dividends here
What is Daicel’s EPS estimate?
Daicel’s EPS estimate is 38.89.
How many shares outstanding does Daicel have?
Daicel has 266,942,700 shares outstanding.
What happened to Daicel’s price movement after its last earnings report?
Daicel reported an EPS of -¥96.24 in its last earnings report, missing expectations of ¥51.879. Following the earnings report the stock price went down -7.58%.
Which hedge fund is a major shareholder of Daicel?
Currently, no hedge funds are holding shares in JP:4202
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Daicel
Daicel Corporation manufactures and sells cellulosic derivatives, organic chemicals, plastics, pyrotechnic devices, and other products in Japan, Asia, North America, and Europe. It operates through Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and Others segments. The company offers 1,3-Butylene glycol, polyglycerin, and thickener for cosmetics; natural health food materials and supplements; and chiral and achiral columns, chiral reagents, bio reagents, and DNA and RNA-based probes, as well as analytical/purification/synthesis/formulation services, and analytical tools services for pharmaceuticals. It also provides triacetylcellulose and films for display market; solvent for electronic materials, polymers for resist, and semiconductor process cleaning agents; and optical parts and lens units, silver nanoparticle inks, and organic semiconductor devices for visualization technology. In addition, the company offers inflators for air bags and pyro-fuse for automotive market, as well as safety device for non-mobility products; acetic acid and derivatives, cellulose acetate, acetate tow, and other raw materials for resins and inks, and solvents for paints; and cycloaliphatic epoxies, caprolactone, ketene derivatives, alkylamines, and other raw materials for electrical materials and coatings. Further, it provides a range of plastics, such as engineering plastics, plastic compound products, functional sheets, formed trays, and packaging films for engineering plastics segment. Additionally, the company manufactures and distributes water treatment systems and diffusers for a range of industrial applications. Its products are used in transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and headquartered in Osaka, Japan.
4202 Stock 12 Month Forecast
Average Price Target
¥1,440.00
▲(15.43% Upside)
Technical Analysis
Kaneka
―
Mitsubishi Gas Chemical Company
―
UBE Industries
―
Zeon
―
Sumitomo Bakelite Co., Ltd.
―
Options Prices
Currently, No data available
---